Posted on February 3rd 2020
Healthcare professionals from all over the world will come together in June for the fourth International CTEPH Conference.
Held every three years, the International CTEPH Conference (ICC) is dedicated to Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and this year, 450 delegates are expected to attend the event in Bad Nauheim, Germany.
Organised by the International CTEPH Association (ICA), ICC 2020 aims to educate physicians on the latest developments in the field; including diagnosis, patient management, medical therapy and interventional treatments.
It will bring together healthcare professionals and patient organisations from around the world to benefit from global networking and collaborative opportunities.
The inaugural event was held in Cambridge in 2011, followed by conferences in Paris in 2014 and in Leuven in 2017. In 2023, the event will head to San Diego.
Dr. Joanna Pepke-Zaba (pictured) of Royal Papworth Hospital is part of the scientific committee underpinning the organisation of the conference.
She said: “The event aims to capture the developments and innovations in this rapidly progressing area of pulmonary hypertension specifically in CTEPH, and to further improve awareness of CTEPH among physicians and health professionals.
“Networking is a vital part of the programme. It allows people to exchange their experiences, explore joint projects, invigorate old acquaintances and make new ones too. There is nothing else like this in the world for CTEPH, on an international stage; it’s really quite unique.”
As well as a programme of talks and presentations, an exhibition area will showcase the latest products and innovations.
Researchers are being invited to submit abstracts (overviews of research projects) and to display their findings in the form of posters. There will also be the opportunity for four abstracts, selected by the abstract review committee, to be presented as talks to delegates during a plenary session.
Dr. Pepke-Zaba said: “The call for abstracts is a very important part of the event, as we hope to stimulate young investigators by allowing them to present their work in CTEPH.
“The number of abstracts we have received has hugely increased since the first conference. We had over 80 at the last event, and the quality of those posters was absolutely fantastic.”
She added: “The management of patients with CTEPH is steadily progressing and we have different treatment modalities now, each delivered by different specialists. So, it’s very important that all these people coming from different specialties come together and discuss up-to-date discoveries and approaches – and take that knowledge back home. Ultimately, this event will be of benefit to patients all over the world.”
